Comparative Assessment of Serum Selenium Status in HIV-Infected and Non-infected Children: A Pilot Study in a Tertiary Hospital in Nigeria

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Jun 30

PMID 37388617

Authors

Sarah O John-Olabode

Patricia Akintan

Kehinde S Okunade

Iwuchukwu Ajie

Affiliations

Soon will be listed here.

Abstract

Background Selenium is an essential micronutrient that plays a crucial role in a wide range of physiological processes, including immune responses. Selenium deficiency has been recognized as an associated factor in the progression of HIV to advanced HIV disease and/or mortality. Although selenium supplementation has been shown to reduce hospitalizations and improve cellular immunity, the evidence remains mixed. This study aimed to determine the prevalence of selenium deficiency and its relationship with HIV disease markers in HIV-infected children at the Lagos University Teaching Hospital. Methodology This is a cross-sectional, comparative, pilot study of plasma concentrations of selenium in HIV-infected (n = 30) and non-infected (n = 20) children enrolled in the pediatric HIV clinic of the Lagos University Teaching Hospital, Lagos, Nigeria, from May 2019 to May 2021. HIV-infected children were on stable antiretroviral therapy (ART) with an undetectable viral load. The serum concentration of selenium was measured using the automated atomic absorption spectrophotometer (hydride generation method). Logistic regression was used to study the effect of selenium status on the levels of HIV disease markers (CD4 count, viral load, weight, opportunistic infections) in the study participants. Results The median age of all participants was nine (4-12) years, with 74% being boys. The mean selenium concentrations were lower in HIV-infected children (91.1 ± 12.0 µg/L) compared to the comparison group without HIV (147.8 ± 4.9 µg/L) (p = 0.001). After controlling for age, ART duration, markers of HIV infection, and other potentially confounding variables, participants with selenium deficiency had approximately 11-fold odds of increased hospital admissions (adjusted odds ratio = 10.57, 95% confidence interval = 1.58 to 70.99; p = 0.015). Conclusions In this study, selenium concentrations were significantly lower in HIV-infected children than in the HIV-negative comparison group. Lower serum selenium concentrations were associated with increased hospitalizations. Although our findings suggest the potential need for selenium supplementation for children living with HIV in Nigeria, further studies are warranted to determine the safety and efficacy of selenium supplementation in this key population.

References

Choi R, Kim H, Lim Y, Kim M, Kwon O, Jeon K . Serum Concentrations of Trace Elements in Patients with Tuberculosis and Its Association with Treatment Outcome. Nutrients. 2015; 7(7):5969-81. PMC: 4517040. DOI: 10.3390/nu7075263. View

Dworkin B . Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact. 1994; 91(2-3):181-6. DOI: 10.1016/0009-2797(94)90038-8. View

Anyabolu H, Adejuyigbe E, Adeodu O . Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: A Case Controlled Study. AIDS Res Treat. 2014; 2014:351043. PMC: 4144154. DOI: 10.1155/2014/351043. View

Zhang W, Ramanathan C, Nadimpalli R, Bhat A, Cox A, Taylor E . Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Elem Res. 1999; 70(2):97-116. DOI: 10.1007/BF02783852. View

Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D . Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol. 1999; 20(5):508-13. DOI: 10.1097/00042560-199904150-00015. View

Constans J, Pellegrin J, Sergeant C, Simonoff M, Pellegrin I, Fleury H . Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10(3):392. DOI: 10.1097/00042560-199511000-00015. View

Dirajlal-Fargo S, Shan L, Sattar A, Kulkarni M, Bowman E, Funderburg N . Micronutrients, Metabolic Complications, and Inflammation in Ugandan Children With HIV. J Pediatr Gastroenterol Nutr. 2020; 70(5):e100-e105. PMC: 7183888. DOI: 10.1097/MPG.0000000000002630. View

Mellors J, Rinaldo Jr C, Gupta P, White R, Todd J, Kingsley L . Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996; 272(5265):1167-70. DOI: 10.1126/science.272.5265.1167. View

Beck M, Handy J, Levander O . Host nutritional status: the neglected virulence factor. Trends Microbiol. 2004; 12(9):417-23. PMC: 7127785. DOI: 10.1016/j.tim.2004.07.007. View

10.

Stone C, Kawai K, Kupka R, Fawzi W . Role of selenium in HIV infection. Nutr Rev. 2010; 68(11):671-81. PMC: 3066516. DOI: 10.1111/j.1753-4887.2010.00337.x. View

11.

Kupka R, Msamanga G, Spiegelman D, Morris S, Mugusi F, Hunter D . Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr. 2004; 134(10):2556-60. DOI: 10.1093/jn/134.10.2556. View

12.

Periquet B, Jammes N, Lambert W, Tricoire J, Moussa M, Garcia J . Micronutrient levels in HIV-1-infected children. AIDS. 1995; 9(8):887-93. DOI: 10.1097/00002030-199508000-00009. View

13.

Shivakoti R, Christian P, Yang W, Gupte N, Mwelase N, Kanyama C . Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clin Nutr. 2015; 35(1):183-189. PMC: 4531105. DOI: 10.1016/j.clnu.2015.02.002. View

14.

Huang Z, Rose A, Hoffmann P . The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011; 16(7):705-43. PMC: 3277928. DOI: 10.1089/ars.2011.4145. View

15.

Rayman M . The importance of selenium to human health. Lancet. 2000; 356(9225):233-41. DOI: 10.1016/S0140-6736(00)02490-9. View

16.

Shivakoti R, Ewald E, Gupte N, Yang W, Kanyama C, Cardoso S . Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr. 2018; 38(3):1303-1309. PMC: 6265110. DOI: 10.1016/j.clnu.2018.05.014. View

17.

Baum M, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher M . High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 15(5):370-4. DOI: 10.1097/00042560-199708150-00007. View

18.

Burbano X, Miguez-Burbano M, McCollister K, Zhang G, Rodriguez A, Ruiz P . Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials. 2002; 3(6):483-91. DOI: 10.1310/A7LC-7C9V-EWKF-2Y0H. View

19.

Zhao L, Cox A, Ruzicka J, Bhat A, Zhang W, Taylor E . Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci U S A. 2000; 97(12):6356-61. PMC: 18607. DOI: 10.1073/pnas.97.12.6356. View

20.

Kassu A, Yabutani T, Mahmud Z, Mohammad A, Nguyen N, Huong B . Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur J Clin Nutr. 2005; 60(5):580-6. DOI: 10.1038/sj.ejcn.1602352. View